Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi

Nathan Wiederhold, Thomas F Patterson, Anand Srinivasan, Ashok K. Chaturvedi, Annette W. Fothergill, Floyd L. Wormley, Anand K. Ramasubramanian, José L. Lopez-Ribot

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Repositioning old drugs can significantly decrease the time and effort that it takes to develop novel antifungal therapeutics, which represents a pressing and unmet clinical need due to the devastating nature of fungal infections. We have previously described the activity of auranofin, a gold thiol compound used to treat rheumatoid arthritis, against Candida albicans biofilms. Here we evaluate its antifungal spectrum of action and describe its activity against a variety of medically important fungi.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalVirulence
DOIs
StateAccepted/In press - Jun 24 2016

Keywords

  • antifungal susceptibility
  • auranofin
  • repurposing
  • spectrum of action

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology
  • Parasitology
  • Immunology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi'. Together they form a unique fingerprint.

  • Cite this

    Wiederhold, N., Patterson, T. F., Srinivasan, A., Chaturvedi, A. K., Fothergill, A. W., Wormley, F. L., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (Accepted/In press). Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi. Virulence, 1-5. https://doi.org/10.1080/21505594.2016.1196301